These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29231028)

  • 1. [Confirming Indicators of Qualitative Results by Chromatography-mass Spectrometry in Biological Samples].
    Liu SD; Zhang DM; Zhang W; Zhang WF
    Fa Yi Xue Za Zhi; 2017 Apr; 33(2):181-188. PubMed ID: 29231028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry.
    Grapp M; Kaufmann C; Streit F; Binder L
    Forensic Sci Int; 2018 Jun; 287():63-73. PubMed ID: 29649771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review.
    Peters FT; Remane D
    Anal Bioanal Chem; 2012 Jun; 403(8):2155-72. PubMed ID: 22549818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of fenspiride: goals and objectives for chemical and toxicological studies].
    Kalekin RA; Orlova AM; Savchuk SA; Barsegyan SS
    Sud Med Ekspert; 2019; 62(4):37-41. PubMed ID: 31407704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometry for Research and Application in Therapeutic Drug Monitoring or Clinical and Forensic Toxicology.
    Maurer HH
    Ther Drug Monit; 2018 Aug; 40(4):389-393. PubMed ID: 29750739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) and high performance liquid chromatography with photodiode array detector (HPLC-DAD) in systematic toxicological analysis.
    Broecker S; Pragst F; Bakdash A; Herre S; Tsokos M
    Forensic Sci Int; 2011 Oct; 212(1-3):215-26. PubMed ID: 21764531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.
    Maurer HH
    J Mass Spectrom; 2006 Nov; 41(11):1399-413. PubMed ID: 17051522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry.
    Gottardo R; Bortolotti F; De Paoli G; Pascali JP; Miksík I; Tagliaro F
    J Chromatogr A; 2007 Aug; 1159(1-2):185-9. PubMed ID: 17240388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control.
    Ojanperä I; Kolmonen M; Pelander A
    Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical methods for determination of anticoagulant rodenticides in biological samples.
    Imran M; Shafi H; Wattoo SA; Chaudhary MT; Usman HF
    Forensic Sci Int; 2015 Aug; 253():94-102. PubMed ID: 26115225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry vs. immunoassay in clinical and forensic toxicology: qui modus in rebus est?
    Busardò FP; Pacifici R; Pichini S
    Clin Chem Lab Med; 2017 Aug; 55(10):e236-e237. PubMed ID: 28672772
    [No Abstract]   [Full Text] [Related]  

  • 13. Retention Time of Four Common Poisons （Drugs） by GC-MS Qualitative Analysis.
    Liu SD; Min T; Wang M; Zhang DM
    Fa Yi Xue Za Zhi; 2018 Jun; 34(6):595-600. PubMed ID: 30896095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
    Fels H; Dame T; Sachs H; Musshoff F
    Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted toxicological screening for acidic, neutral and basic substances in postmortem and antemortem whole blood using simple protein precipitation and UPLC-HR-TOF-MS.
    Telving R; Hasselstrøm JB; Andreasen MF
    Forensic Sci Int; 2016 Sep; 266():453-461. PubMed ID: 27458995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance.
    Frison G; Zamengo L; Zancanaro F; Tisato F; Traldi P
    Rapid Commun Mass Spectrom; 2016 Jan; 30(1):151-60. PubMed ID: 26661982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatography/time-of-flight mass spectrometry analysis of postmortem blood samples for targeted toxicological screening.
    Roman M; Ström L; Tell H; Josefsson M
    Anal Bioanal Chem; 2013 May; 405(12):4107-25. PubMed ID: 23455644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TagFinder for the quantitative analysis of gas chromatography--mass spectrometry (GC-MS)-based metabolite profiling experiments.
    Luedemann A; Strassburg K; Erban A; Kopka J
    Bioinformatics; 2008 Mar; 24(5):732-7. PubMed ID: 18204057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology.
    Schwaninger AE; Meyer MR; Maurer HH
    J Chromatogr A; 2012 Dec; 1269():122-35. PubMed ID: 22858363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of liquid chromatography-high resolution mass spectrometry in toxicological screening].
    Li XW; Shen BH; Zhuo XY
    Fa Yi Xue Za Zhi; 2011 Oct; 27(5):376-81. PubMed ID: 22259869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.